Updated daily
# | PubMedId | Deleted | Publication |
---|---|---|---|
35918731 | 0 | Holbrook AM, Vidug K, Yoo L, et al. Coordination of Oral Anticoagulant Care at Hospital Discharge (COACHeD): protocol for a pilot randomised controlled trial. Pilot Feasibility Stud. 2022 Aug 2;8(1):166. doi: 10.1186/s40814-022-01130-z. | |
35697453 | 0 | Wang M, Paterson M, Thabane L, et al. Association of direct oral anticoagulant-proton pump inhibitor cotherapy with adverse outcomes: protocol for a population-based cohort study. BMJ Open. 2022 Jun 13;12(6):e057991. doi: 10.1136/bmjopen-2021-057991. | |
34587197 | 0 | Holbrook A, Wang M, Swinton M, et al. Barriers and facilitators for optimizing oral anticoagulant management: Perspectives of patients, caregivers, and providers. PLoS One. 2021 Sep 29;16(9):e0257798. doi: 10.1371/journal.pone.0257798. eCollection 2021. | |
34391064 | 0 | Benipal H, Holbrook A, Paterson JM, et al. Derivation and validation of predictors of oral anticoagulant-related adverse events in seniors transitioning from hospital to home. Thromb Res. 2021 Oct;206:18-28. doi: 10.1016/j.thromres.2021.07.016. Epub 2021 Aug 2. | |
33863794 | 0 | Holbrook A, Benipal H, Paterson JM, et al. Adverse event rates associated with oral anticoagulant treatment early versus later after hospital discharge in older adults: a retrospective population-based cohort study. CMAJ Open. 2021 Apr 16;9(2):E364-E375. doi: 10.9778/cmajo.20200138. Print 2021 Apr-Jun. | |
33769581 | 0 | Wang M, Zeraatkar D, Obeda M, et al. Drug-drug interactions with warfarin: A systematic review and meta-analysis. Br J Clin Pharmacol. 2021 Nov;87(11):4051-4100. doi: 10.1111/bcp.14833. Epub 2021 May 16. | |
33649169 | 0 | Little DHW, Sutradhar R, Cerasuolo JO, et al. Rates of rebleeding, thrombosis and mortality associated with resumption of anticoagulant therapy after anticoagulant-related bleeding. CMAJ. 2021 Mar 1;193(9):E304-E309. doi: 10.1503/cmaj.201433. | |
33000892 | 0 | Little DHW, Robertson T, Douketis J, et al. Management of antithrombotic therapy after gastrointestinal bleeding: A mixed methods study of health-care providers. J Thromb Haemost. 2021 Jan;19(1):153-160. doi: 10.1111/jth.15111. Epub 2020 Oct 21. | |
32320170 | 0 | Holbrook A, Morrow R, Lee AYY, et al. Comparative effectiveness and safety of oral anticoagulants for atrial fibrillation: A retrospective cohort study. J Popul Ther Clin Pharmacol. 2020 Apr 13;27(2):e28-e44. doi: 10.15586/jptcp.v27i2.662. | |
31434018 | 0 | Xu Y, Schulman S, Dowlatshahi D, et al. Healthcare resource utilization and costs among patients with direct oral anticoagulant or warfarin-related major bleeding. Thromb Res. 2019 Oct;182:12-19. doi: 10.1016/j.thromres.2019.07.026. Epub 2019 Aug 2. | |
31138592 | 0 | Paquette M, Witt DM, Holbrook A, et al. A systematic review and meta-analysis of supplemental education in patients treated with oral anticoagulation. Blood Adv. 2019 May 28;3(10):1638-1646. doi: 10.1182/bloodadvances.2019000067. | |
30850385 | 0 | Khatib R, Ludwikowska M, Witt DM, et al. Vitamin K for reversal of excessive vitamin K antagonist anticoagulation: a systematic review and meta-analysis. Blood Adv. 2019 Mar 12;3(5):789-796. doi: 10.1182/bloodadvances.2018025163. | |
30658963 | 0 | Piran S, Khatib R, Schulman S, et al. Management of direct factor Xa inhibitor-related major bleeding with prothrombin complex concentrate: a meta-analysis. Blood Adv. 2019 Jan 22;3(2):158-167. doi: 10.1182/bloodadvances.2018024133. | |
30482765 | 0 | Witt DM, Nieuwlaat R, Clark NP, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy. Blood Adv. 2018 Nov 27;2(22):3257-3291. doi: 10.1182/bloodadvances.2018024893. | |
29948370 | 0 | Li G, Lip GYH, Holbrook A, et al. Direct comparative effectiveness and safety between non-vitamin K antagonist oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation: a systematic review and meta-analysis of observational studies. Eur J Epidemiol. 2019 Feb;34(2):173-190. doi: 10.1007/s10654-018-0415-7. Epub 2018 Jun 8. | |
28594478 | 0 | Jegathisawaran J, Holbrook A, Bowen JM, et al. What Influences the Cost Effectiveness of Dabigatran versus Warfarin for Stroke Prevention in Atrial Fibrillation: A Systematic Review. J Popul Ther Clin Pharmacol. 2017 May 2;24(2):e1-e20. doi: 10.22374/1710-6222.24.2.1. | |
28219635 | 0 | Xu Y, Schulman S, Dowlatshahi D, et al. Direct Oral Anticoagulant- or Warfarin-Related Major Bleeding: Characteristics, Reversal Strategies, and Outcomes From a Multicenter Observational Study. Chest. 2017 Jul;152(1):81-91. doi: 10.1016/j.chest.2017.02.009. Epub 2017 Feb 17. | |
27884850 | 0 | Holbrook A, Dormuth C, Morrow R, et al. Comparative effectiveness and safety of oral anticoagulants for atrial fibrillation in real-world practice: a population-based cohort study protocol. BMJ Open. 2016 Nov 24;6(11):e013263. doi: 10.1136/bmjopen-2016-013263. | |
27513986 | 0 | Li G, Thabane L, Delate T, et al. Can We Predict Individual Combined Benefit and Harm of Therapy? Warfarin Therapy for Atrial Fibrillation as a Test Case. PLoS One. 2016 Aug 11;11(8):e0160713. doi: 10.1371/journal.pone.0160713. eCollection 2016. | |
27388221 | 0 | Fatima S, Holbrook A, Schulman S, et al. Development and validation of a decision aid for choosing among antithrombotic agents for atrial fibrillation. Thromb Res. 2016 Sep;145:143-8. doi: 10.1016/j.thromres.2016.06.015. Epub 2016 Jun 16. | |
27370013 | 0 | Li G, Holbrook A, Jin Y, et al. Comparison of treatment effect estimates of non-vitamin K antagonist oral anticoagulants versus warfarin between observational studies using propensity score methods and randomized controlled trials. Eur J Epidemiol. 2016 Jun;31(6):541-61. doi: 10.1007/s10654-016-0178-y. Epub 2016 Jul 1. | |
27203185 | 0 | Barnes GD, Izzo B, Conte ML, et al. Use of decision aids for shared decision making in venous thromboembolism: A systematic review. Thromb Res. 2016 Jul;143:71-5. doi: 10.1016/j.thromres.2016.05.009. Epub 2016 May 12. | |
26546146 | 0 | Li G, Holbrook A, Delate T, et al. Prediction of individual combined benefit and harm for patients with atrial fibrillation considering warfarin therapy: a study protocol. BMJ Open. 2015 Nov 5;5(11):e009518. doi: 10.1136/bmjopen-2015-009518. | |
26356708 | 0 | Li G, Cook DJ, Levine MAH, et al. Competing Risk Analysis for Evaluation of Dalteparin Versus Unfractionated Heparin for Venous Thromboembolism in Medical-Surgical Critically Ill Patients. Medicine (Baltimore). 2015 Sep;94(36):e1479. doi: 10.1097/MD.0000000000001479. | |
25676955 | 0 | Chackery DG, Keshavjee K, Mirza K, et al. Integrating Clinical Decision Support into EMR and PHR: a Case Study Using Anticoagulation. Stud Health Technol Inform. 2015;208:98-103. |